This post was originally published on this site
“Novartis is fully cooperating with authorities and is confident to clarify legitimacy of its position,” it said in a statement, adding that the opening of an investigation did not imply any wrongdoing or financial impact.
Novartis will not comment further on the investigation at this time, it added.
